Treatment for mild asthma leads to improved lung function

A study by the Woolcock Institute of Medical Research in Sydney is the first to demonstrate that in patients with very mild or well-controlled asthma, regular treatment with low dose ICS leads to significantly better day–to-day lung function.

The study published in this month’s edition of Primary Care Respiratory Journal was conducted over an 11 month period, and compared the effects of inhaled corticosteroids (ICS) and placebo on asthma control in mild asthmatics.

The results of the study raise questions about the current emphasis in asthma treatment which is based largely on controlling symptoms, and which does not advocate ICS treatment for patients with symptoms two days a week or less.

Results showed significant and clinically important treatment benefits on markers such as lung function, airway hyperresponsiveness and exhaled nitric oxide, which are all predictors of the risk of future adverse outcomes such as exacerbations.

Results indicated that a “ceiling” effect for lung function, often assumed to prevail in mild asthma, does not exist. Even patients whose lung function is over 90% of predicted normal value may have room to further improve their personal best with treatment.

The study also demonstrated subjects receiving placebo were nearly three times more likely to experience a mild exacerbation.

“In recent years the emphasis in asthma treatment has been on how well a patient’s symptoms are is controlled,” says Woolcock research leader Assoc. Prof. Helen Reddel.

“The patients in this study had asthma that was so mild, with symptoms once a week or less, that they themselves didn’t see any benefit in regular preventer treatment,” she said.

“However for those participants receiving ICS during the study, their lung function was better, they had less airway inflammation and less airway twitchiness. All of these things are predictors of reduction in risk of future adverse outcomes

“While we’re not advocating that every patient with mild asthma should be on preventer medication, the study shows that when we are discussing the risks and benefits of treatment with these patients, we should talk about their risk of future exacerbations as well as whether they will notice any difference in their current symptoms”.

“In the same way, for patients with high blood pressure, we talk about giving treatment to reduce their risk of stroke in the future rather than whether they will feel any different here and now.”

Dr Reddel explains that while the study sample size was small, the measurement of airway twitchiness, airway inflammation and daily spirometry provided information about future risk that is often not possible in larger groups.

Source: Research Australia

Related stories:

New breathing exercises help manage asthma
A presentation that demonstrates breathing exercises designed to help reduce the use of asthma inhalers is today available to the general public for free from the Cooperative Research Centre (CRC) for Asthma and Airways website.
Personalized therapy for asthma and COPD could soon be here
Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.
Researchers light up lungs to help diagnose disease
Researchers at the University of Sheffield have developed innovative technology which illuminates a person’s lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.
First do no harm? UH prof taking opposite approach to treat asthma
One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor.
Depressed caregivers hostile, not warm, to children
A new study in the journal Family Process reveals that caregivers with moderate to severe depressive symptoms showed greater hostility and less warmth. The study focused on caregivers of low-income children with persistent asthma.
Surgery improves quality of life for children with sleep apnea
For children who suffer from obstructive sleep apnea (OSA), a tonsillectomy and adenoidectomy can provide dramatic relief and is successful in solving sleep problems for 80 to 90 percent of children, a Saint Louis University study found.
Severe asthma may be a different form of the disease
A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment.
Discovery suggests protein may play a role in severe asthma
A protein measured in a simple blood test may be a new biomarker to identify patients with the most serious form of asthma, Yale School of Medicine researchers report today in the New England Journal of Medicine.

News discussion:

Medicine & Health news